GEHC|Analyst Targets
GEHC|Company Info
GEHC|Insider Trading
GEHC|Fundamentals
GEHC|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.21 | - | - |
| Q2'26 | $1.04 | $1.13 | +9.1% |
| Q1'26 | $1.05 | $0.99 | -5.7% |
| Q4'25 | $1.43 | $1.44 | +1.0% |
| Q3'25 | $1.05 | $1.07 | +2.2% |
| Q2'25 | $0.92 | $1.06 | +15.4% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $5.5B | - | - |
| Q2'26 | $5.4B | $5.3B | -1.4% |
| Q1'26 | $5.0B | $5.1B | +2.1% |
| Q4'25 | $5.7B | $5.7B | -0.4% |
| Q3'25 | - | $5.1B | - |
| Q2'25 | - | $5.0B | - |
GEHC|Monthly Returns
Market Data
GEHC Stock Snapshot
- Market cap
- 31.07B
- P/E ratio
- 15.7
- Day range
- $67.66 – $69.51
- News sentiment
- 37/100 · Bearish
- Analyst target
- $82.70 (+20.9%)
- Consensus
- Buy · 30 analysts
GEHC is on the weaker side of its setup, with little confirmation for a reversal yet. The stock is liquid enough that positioning changes get absorbed without distorting the trend.
Reverse DCF
What growth is priced into GEHC?
At today's price, GE HealthCare Technologies Inc. needs to grow free cash flow about 11.1% a year for the next 10 years to justify its valuation at a 8.48% cost of capital. Over its actual history it has compounded free cash flow at 0.4% a year, so the market is asking for 10.7 percentage points above its own delivered rate. On that basis GEHC looks priced above what its own growth record supports.
- Implied FCF growth
- 11.1%
- Historical FCF CAGR
- 0.4%
- Growth gap
- +10.7 pts
- Verdict
- RICH
- Discount rate (WACC)
- 8.48%
- Beta
- 0.98
Behaviour On Record
What GEHC's own history says about today's numbers
- Realized volatility (21d)
- 23.5% 28th pct
- Below its peak
- -26.8%
- vs 200-day average
- -2.8%
- Up days (1y)
- 50%
GE HealthCare Technologies Inc. is currently running 23.5% annualised volatility over the last 21 sessions. Measured against GEHC's own 4 years of daily returns rather than a market-wide average, that is the 28th percentile — on the quiet side for this stock, against a typical reading of 28.6%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
GEHC is trading -26.8% below its running peak. Across 3 full years on file, its median worst-drawdown-in-a-year was -27.6%, and the deepest was -37.8% in 2025. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits -2.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 44th percentile — close to the gap it normally carries. Over the past year GEHC closed higher on 50% of sessions, and it is currently 3 sessions into a rising streak.
Overnight risk is measurable too: GEHC has opened more than 2% away from the prior close in 20 of 958 sessions (2.1% of the time), with the largest gaps running +6.6% and -6.6%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, GEHC moved an average of 2.3% in the session after earnings, closing higher 2 of those 3 times, with a median move of +1.5% and a largest of -2.8%.
All figures computed from 959 daily closes between 2022-12-15 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against GEHC's own 4-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of GEHC's sector?
GE HealthCare Technologies Inc. sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
Analyst Rating Changes
Are analysts turning bullish or bearish on GEHC?
BTIG most recently reiterated its rating on GE HealthCare Technologies Inc. to Buy on Oct 12, 2026 with a price target of $75 (from $79). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- BTIG — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Peers & ETF holders
GEHC peers & ETF holders
Medical DevicesMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▲ Buy | 52,275,767 | 11.58% | $4.29B | 2026-01-29 |
| BlackRock, Inc. | ▲ Buy | 37,467,843 | 8.30% | $2.40B | 2026-08-07 |
| Invesco Ltd. | ▲ Buy | 18,296,350 | 4.05% | $1.17B | 2026-08-14 |
| Harris Associates L P | ▼ Sell | 15,329,664 | 3.39% | $981.25M | 2026-08-14 |
| Geode Capital Management, LLC | ▲ Buy | 12,871,800 | 2.85% | $820.82M | 2026-08-12 |
| JPMorgan Chase & Co | ▲ Buy | 10,329,164 | 2.29% | $671.91M | 2026-08-12 |
| Morgan Stanley | ▼ Sell | 6,223,322 | 1.38% | $398.36M | 2026-08-13 |
| Norges Bank | ▼ Sell | 5,823,524 | 1.29% | $372.76M | 2026-08-12 |
| Goldman Sachs Group Inc | ▲ Buy | 4,446,565 | 0.98% | $284.62M | 2026-08-14 |
| Northern Trust Corp | ▼ Sell | 3,938,748 | 0.87% | $252.12M | 2026-08-13 |
| Bank of America Corp | ▼ Sell | 3,249,771 | 0.72% | $208.02M | 2026-08-14 |
| FMR LLC (Fidelity) | ▲ Buy | 3,155,095 | 0.70% | $201.96M | 2026-08-13 |
| Trian Fund Management, L.P. | ▲ Buy | 3,085,344 | 0.68% | $197.49M | 2026-08-12 |
| Temasek Holdings (Private) Ltd | ▼ Sell | 2,515,393 | 0.56% | $161.01M | 2026-08-07 |
| Citadel Advisors LLC | ▲ Buy | 2,367,032 | 0.52% | $151.51M | 2026-09-02 |
| Point72 Asset Management, L.P. | ▲ Buy | 1,165,973 | 0.26% | $74.63M | 2026-08-14 |
| Wells Fargo & Company | ▼ Sell | 879,516 | 0.19% | $56.30M | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 850,374 | 0.19% | $54.43M | 2026-08-03 |
| AQR Capital Management LLC | ▲ Buy | 696,084 | 0.15% | $44.33M | 2026-08-14 |
| Gotham Asset Management, LLC | ▲ Buy | 584,395 | 0.13% | $37.41M | 2026-08-14 |
| AllianceBernstein L.P. | ▼ Sell | 518,346 | 0.11% | $36.90M | 2026-08-14 |
| Squarepoint Ops LLC | ▲ Buy | 446,431 | 0.10% | $28.58M | 2026-08-14 |
| D. E. Shaw & Co., Inc. | ▼ Sell | 418,089 | 0.09% | $26.76M | 2026-08-14 |
| Capital Research Global Investors | ▼ Sell | 394,148 | 0.09% | $25.23M | 2026-08-12 |
| Susquehanna International Group, LLP | ▲ Buy | 314,867 | 0.07% | $20.15M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Alan Armstrong | Senate | OK | ▲ Buy | $1K - $15K | 2026-03-27 | 2026-07-21 |
| Terri A. Sewell | House | AL07 | ▼ Sell | $1K - $15K | 2026-03-25 | 2026-04-21 |
| Warren Davidson | House | OH08 | ▼ Sell | $1K - $15K | 2026-03-23 | 2026-03-25 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-05-15 | 2025-05-31 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-04-08 | 2025-04-28 |
| Austin Scott | House | GA08 | ▼ Sell | $1K - $15K | 2025-03-27 | 2025-08-13 |
| Rob Bresnahan | House | PA08 | ▲ Buy | $1K - $15K | 2025-02-25 | 2025-03-27 |